Indeed, our data demonstrated that NRF2 knockdown effectively reversed HACE1-mediated decreased radiosensitivity of glioma cells and promoting effect of HACE1 on cellular GSH levels, strongly supporting the above hypothesis. Here, HACE1 is linked to central nervous system cancer.